Status Approved
First Submitted Date
2019/11/11
Registered Date
2019/11/19
Last Updated Date
2019/11/11
CRIS Required
WHO ICTRP (International Clinical Trial Registry Platform) Required
1. Background
CRIS Registration Number |
KCT0004448 |
---|---|
Unique Protocol ID | 2-2016-0044 |
Public/Brief Title | Clinical study of high added value food material for periodontal disease prevention and improvement |
Scientific Title | Clinical study of high added value food material for periodontal disease prevention and improvement |
Acronym | |
MFDS Regulated Study | No |
IND/IDE Protocol | |
Registered at Other Registry | No |
Healthcare Benefit Approval Status | Not applicable |
2. Institutional Review Board / Ethics Committee
Board Approval Status | Submitted approval |
---|---|
Board Approval Number | 2-2016-0044 |
Approval Date | 2017-01-26 |
Institutional Review Board Name | Institutional Review Board of Yonsei University Dental Hospital |
Institutional Review Board Address | 50-1, Yonsei-ro, Seodaemun-gu, Seoul |
Institutional Review Board Telephone | 02-2228-8613 |
Data Monitoring Committee | No |
3. Contact Details
Contact Person for Principal Investigator / Scientific Queries | |
---|---|
Name | Seong-Ho Choi |
Title | Prof |
Telephone | +82-2-2228-8820 |
Affiliation | Yonsei University Health System, Dental Hospital |
Address | Department of Periodontology, 3F, Yonsei University Dental Hospital, Yonsei-ro 50-1. Seodaemun-gu, Seoul |
Contact Person for Public Queries | |
Name | Inpyo Hong |
Title | Resident |
Telephone | +82-2-2228-8820 |
Affiliation | Yonsei University Health System, Dental Hospital |
Address | Department of Periodontology, 3F, Yonsei University Dental Hospital, Yonsei-ro 50-1. Seodaemun-gu, Seoul |
Contact Person for Updating Information | |
Name | Inpyo Hong |
Title | Resident |
Telephone | +82-2-2228-8820 |
Affiliation | Yonsei University Health System, Dental Hospital |
Address | Department of Periodontology, 3F, Yonsei University Dental Hospital, Yonsei-ro 50-1. Seodaemun-gu, Seoul |
4. Status
Study Site | Single | |
---|---|---|
Overall Recruitment Status | Completed | |
Date of First Enrollment | 2017-06-14 Actual | |
Target Number of Participant | 100 | |
Primary Completion Date | 2018-11-30 , Actual | |
Study Completion Date | 2018-11-30 , Actual | |
Recruitment Status by Participating Study Site 1 | ||
Name of Study | Yonsei University Health System, Dental Hospital | |
Recruitment Status | Completed | |
Date of First Enrollment | 2017-06-14 , |
5. Source of Monetary / Material Support
1. Source of Monetary/Material Support | |
---|---|
Organization Name | Ministry of Agriculture, Food and Rural Affairs |
Organization Type | Government |
Project ID |
6. Sponsor Organization
1. Sponsor Organization | |
---|---|
Organization Name | Yonsei University Health System, Dental Hospital |
Organization Type | Medical Institute |
7. Study Summary
Lay Summary | Purpose: Through nationally assigned projects about the development of high value-added food for the prevention and treatment of periodontal disease, the extraction of Ligularia stenocephala and wheat sprout (ELW) was introduced. ELW showed its efficacy in vivo and in vitro. The aim of this clinical study is to determine the efficacy of ELW in prevention and treatment of periodontitis in humans. Backgrounds: - Matrix metalloproteinase (MMP) is induced by inflammatory cytokines and plays a significant role in development of periodontal disease. Since its significant role in periodontal disease, various substances have been developed for inhibition of MMPs. Tetracycline is one of the MMP inhibiting antibiotics, but it has limitations in general application to patients. - There is an over-the-counter medicine for periodontal disease based on unsaponifiable material from saponification of corn. It consists of beta-sitosterol, squalene, carotene tocopherol and more. Beta-sitosterol which is pro-vitamin D is known to be effective for periodontal health, however, there is no sufficient evidence for support. There is controversial that this kind of medicines are just nutrition without any specific efficacy for periodontal health. - Also, there is another type of over-the counter medicine for periodontal disease, which consists of vitamin E, C and inhibiting materials for inflammation and bleeding. This kind of medicines has limitation that it cannot deal with fundamental causes of periodontal disease. Thus, taking this kind of medicine cannot accomplish periodontal health. - Most of medicines for periodontal disease are composed of ascorbic acid, herbal extracts or antibiotics like doxycycline and chlorhexidine. They mainly work as anti-inflammatory and anti-microbial. Only a few studies evaluated specific efficacy to periodontal disease |
---|
8. Study Design
Study Type | Interventional Study |
---|---|
Study Purpose | Supportive Care |
Phase | Not applicable |
Intervention Model | Parallel |
Blinding/Masking | Double |
Blinded Subject | Subject, Investigator |
Allocation | RCT |
Intervention Type | Dietary Supplement |
Intervention Description | - Test group: Extraction of Ligularia stenocephala and wheat sprout (ELW) 300mg capsule (extracted with 50% alcohol), 1 capsule for daily oral intake for 4 weeks _ Control group: Placebo dextrin 300mg capsule with same shape and color with ELW. 1 capsule for daily oral intake for 4 weeks Subjects were randomly assigned to test and control group. There was no intervention to subjects without daily oral intake of assigned capsule. |
Number of Arms | 2 |
Arm 1 |
Arm Label Daily oral intake of a 300mg capsule of extraction of Ligularia stenocephala and wheat sprout (ELW) (extracted with 50% alcohol) |
Target Number of Participant 50 |
|
Arm Type Experimental |
|
Arm Description - Test group: Extraction of Ligularia stenocephala and wheat sprout (ELW) 300mg capsule (extracted with 50% alcohol), 1 capsule for daily oral intake for 4 weeks |
|
Arm 2 |
Arm Label Daily oral intake of placebo dextrin 300mg capsule with same shape and color with ELW |
Target Number of Participant 50 |
|
Arm Type Placebo comparator |
|
Arm Description _ Control group: Placebo dextrin 300mg capsule with same shape and color with ELW. 1 capsule for daily oral intake for 4 weeks |
9. Subject Eligibility
Condition(s)/Problem(s) |
* (K00-K93)Diseases of the digestive system (K05.6)Periodontal disease, unspecified Subjects who are diagnosed as gingivitis or chronic generalized incipient to moderate periodontitis. |
---|---|
Rare Disease | No |
Inclusion Criteria |
Gender Both |
Age 18Year~80Year |
|
Description 1) Male or female whose age is in 18~80 years old 2) Subjects who have more than 18 natural teeth 3) Subjects who have sites with probing depth more than 3mm 4) Subjects who have at least two teeth with bleeding on probing in a sextant 5) Subjects who are diagnosed as gingivitis or chronic generalized incipient to moderate periodontitis |
|
Exclusion Criteria |
1) Subjects who did not sign on a written consent form. 2) Subjects who are pregnant or lactating 3) Subjects who have uncontrolled systemic diseases like severe hypertension and diabetes 4) Subjects who did not enroll in other clinical studies in recent 3 months 5) Subjects who are intaking antiplatelet or anticoagulant or who have hemorrhagic disease 6) Subjects who had cancer in past 5 years. 7) Subjects who had antibiotic therapy in a recent month 8) Subjects who had periodontal treatment in recent six month, except scaling 9) Subjects who have pathologic appearance (e.g: leukoplakia, lichen planus) 10) Subjects who are decide not to be appropriate in clinician's decision 11) Subjects who had allergy in ingredients for medication 12) Subjects who smokes more than 10 cigarrettes / day |
Healthy Volunteers | Yes |
10. Outcome Measure(s)
Type of Primary Outcome | /Safety/Efficacy | |
---|---|---|
Primary Outcome(s) 1 | ||
Outcome | Bleeding on probing, Clinical attachment loss |
|
Timepoint | Every visits. |
|
Secondary Outcome(s) 1 | ||
Outcome | Levels of biomarkers in saliva and gingival crevicular fluid |
|
Timepoint | First visit and last visit |
|
Secondary Outcome(s) 2 | ||
Outcome | Blood test data |
|
Timepoint | First visit and last visit |
11. Study Results and Publication
Result Registered | No |
---|
12. Sharing of Study Data(Deidentified Individual-Patient Data, IPD)
Sharing Statement | No |
---|
TOP
BOTTOM
화면 최하단으로 이동